Physician profile
Kyle Mele
NPI 1801355094
$2,415.27
in general payments reported to CMS, 2019-2025
9 companies · $20.54 in 2025
The $20.54 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $689 · 2024: $1,706 · 2025: $20.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,315 · Food and Beverage: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,314.99 |
| Food and Beverage | $1,100.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,520.16 | 2023-2024 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $527.93 | 2023 | Intellis Adaptivestim, Synchromedii |
| Biotronik Nro, INC. | $147.07 | 2024 | Prospera |
| Nevro Corp. | $65.67 | 2024 | Senza |
| Si-Bone, INC. | $52.13 | 2024 | |
| Bioventus LLC | $36.14 | 2023 | Stimrouter Implantable Kit |
| Vertos Medical, INC. | $25.97 | 2024 | Mild Device Kit |
| Globus Medical, INC. | $20.54 | 2025 | Senza |
| Atricure, INC. | $19.66 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Mele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.